COVID
-
October 28, 2021
Zost honored for research on COVID-19, other life-threatening viral diseases
Vanderbilt's Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. -
October 21, 2021
Study explores impact of COVID-19 on children
-
October 20, 2021
Caring for caregivers
More than 1,000 bags given out Tuesday as part of the Caregivers Need Care Too initiative. -
October 7, 2021
Boosta-Palooza
VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event. -
October 6, 2021
Pediatricians seeing increase in children with MIS-C after latest COVID surge
-
October 5, 2021
AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC
Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19. -
October 1, 2021
VUMC research contributed to first COVID-19 pill now under review
Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.